FDC Limited (BSE: 531599)
Health Care · Pharmaceuticals · IN
Rs330.10
-1.62% today · -27.6% 1Y
FDC Limited (BSE: 531599) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $555.31M.
Over the last twelve months the share price has lost 27.6%, trading between 314.75 and 473.30.
Tweenvest scores FDC Limited across four factors: quality 82/100, value 86/100, growth 22/100, dividend 55/100. Its strongest factor is value.
531599 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $555.31M
- Revenue (TTM)
- $231.64M
- P/E
- 18.36
- EPS
- 17.98
- Dividend yield
- 1.51%
- Beta (5Y)
- 0.20
- 52-week high
- Rs473.30
- 52-week low
- Rs314.75
- Avg volume (3M)
- —
- Shares outstanding
- 162.81M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| CorMedix Inc.NasdaqGM: CRMD | $575.23M | $7.55 | +2.30% |
| Zhejiang Starry Pharmaceutical Co.,Ltd.SHSE: 603520 | $570.75M | CN¥8.72 | -0.34% |
| Gansu Longshenrongfa Pharmaceutical Industry CO.,LTDSZSE: 300534 | $567.01M | CN¥12.52 | -0.48% |
| Aclaris Therapeutics, Inc.NasdaqGS: ACRS | $563.77M | $3.70 | -3.39% |
| Xuanzhu Biopharmaceutical Co., Ltd.SEHK: 2575 | $552.76M | HK$8.38 | -4.56% |
| Kingchem (Liaoning) Life Science Co., Ltd.SZSE: 301509 | $545.04M | CN¥30.31 | -3.01% |
| Xiangxue Pharmaceutical Co.,Ltd.SZSE: 300147 | $542.01M | CN¥5.49 | -6.95% |
| Boryung CorporationKOSE: A003850 | $538.78M | ₩8,610.00 | +2.26% |
Figures last refreshed Oct 11, 2026.